Cerus Corp

CERS NASDAQ
5.57
+0.09
+1.64%
After Hours: 5.57 0 0.00% 16:59 08/19 EDT
Open
5.55
Prev Close
5.48
High
5.61
Low
5.47
Volume
729.89K
Avg Vol (3M)
1.00M
52 Week High
7.81
52 Week Low
4.485
% Turnover
0.51%
Market Cap
781.59M
1D
5D
1M
3M
1Y
5Y

Related

Webull offers Cerus Corp CERS stock price, real time market quotes, professional analyst ratings, and in-depth charts, You can share investing ideas in community to communicate with others and learn trading skills.

Company Profile

Cerus Corporation is a biomedical products company. The Company is engaged in developing and commercializing the INTERCEPT Blood System for blood safety. The Company operates through blood safety segment. The Company's INTERCEPT Blood System is based on its technology for controlling biological replication, and is designed to reduce blood-borne pathogens in donated blood components intended for transfusion. The Company's INTERCEPT Blood System is designed to target and inactivate blood-borne pathogens, such as viruses, including human immunodeficiency virus (HIV), West Nile, Severe acute respiratory syndrome (SARS), hepatitis B and C; bacteria and parasites, as well as harmful white blood cells, while preserving the therapeutic properties of platelet, plasma and red blood cell transfusion products. The Company's INTERCEPT Blood System is for use with blood components, including plasma, platelets, and red blood cells.
MORE >

Recently

Name
Price
%Change